Pinnacle Life Science

What Pinnacle Life Science does

Pinnacle Life Science is an India-based pharmaceutical Contract Development and Manufacturing Organization (CDMO) and wholly-owned subsidiary of Aarti Drugs Limited, founded in 2015 and headquartered in Mumbai with state-of-the-art manufacturing operations in Baddi, Himachal Pradesh. The company operates a multi-approval facility (USFDA, MHRA, EU-GMP, ANVISA, WHO-GMP, MCAZ Zimbabwe GMP) with annual capacity of 3 billion tablet, 300 million capsule, and 100 million oncology oral solid dosage (OSD) units, supplying medicines to 90+ countries through 150+ partners. Its central technical differentiator is OEB Level-5 certified containment infrastructure for high-potency active pharmaceutical ingredient (HPAPI) and cytotoxic oncology manufacturing, with third-party SafeBridge validation to ≤100 ng/m³ using the SMEPAC protocol. The full manufacturing chain (API dispensing, granulation, compression, coating, primary packaging) operates within sealed isolator systems rather than open handling.

The company's product portfolio spans oncology (under OEB Level-5 containment), cardiovascular, anti-infectives, diabetes, CNS, respiratory, dermatology, gastrointestinal, pain management, gynecology, vitamins, and antibiotics, with 80+ finished products divided between regulated-market products (e.g., Apixaban, Rivaroxaban, Sitagliptin, Dapagliflozin) and emerging-market generics. It also offers antibody-drug conjugate (ADC) development and manufacturing services, including bioconjugation and fill-finish. Pinnacle generates revenue through project-specific, quote-driven CDMO contracts covering formulation development, analytical method development, clinical trial material production, commercial-scale manufacturing, regulatory dossier support, and technology transfer, acquired via direct enterprise field sales to global pharmaceutical and biotech clients. Backward integration through parent Aarti Drugs Ltd. provides API supply chain resilience and reduces single-source procurement risk for HPAPI programmes. Marketing relies on content-driven SEO and downloadable brochures rather than outbound sales, and the company positions itself as BIOSECURE Act-compliant for US federal and government-linked pharmaceutical supply chains.

Name

Pinnacle Life Science

Legal name

Pinnacle Life Science

Website

https://pinnaclelifescience.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Pinnacle Life Science is an India-based pharmaceutical CDMO and subsidiary of Aarti Drugs Limited that manufactures tablets, capsules, injectables, and inhalers — including OEB Level-5 oncology HPAPI products — at its USFDA, MHRA, EU-GMP, and ANVISA-approved Baddi facility, serving 90+ countries and 150+ global pharma partners.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing (CDMO)

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

akta.pro secondary industries

Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK), CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD)

Keywords

• Pharmaceutical contract manufacturing
• Oncology CDMO services
• Oral solid dosage manufacturing
• HPAPI manufacturing
• High-potency containment manufacturing

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Infrastructure, Technology or R&D, Operations

Revenue model

1. CDMO Contract Manufacturing Fees: Pinnacle Life Science generates revenue as a Contract Development and Manufacturing Organization (CDMO) by charging pharmaceutical companies for development and manufacturing services. Revenue is earned on a per-project, per-batch, or multi-year contract basis, covering formulation development, analytical method development, clinical trial material production, commercial-scale manufacturing, regulatory dossier preparation, and technology transfer. As a B2B CDMO, pricing is project-specific and quote-driven rather than publicly listed.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Pinnacle Life Science is a pharmaceutical Contract Development and Manufacturing Organization (CDMO) that develops, manufactures, and exports tablets, capsules, injectables, and inhalers for global pharmaceutical clients. The company's flagship capability is OEB Level-5 containment manufacturing of cytotoxic oncology and high-potency API oral solid dosage products, supported by a USFDA-approved Baddi facility with 3 billion tablet / 300 million capsule annual capacity and vertical API integration through parent Aarti Drugs Ltd.

Product overview

Pinnacle Life Science is a Contract Development and Manufacturing Organization (CDMO) that provides end-to-end pharmaceutical manufacturing services. Founded in 2015 as a subsidiary of Aarti Drugs Ltd., the company operates a state-of-the-art manufacturing facility in Baddi, Himachal Pradesh, with capacity of 3 billion tablet units, 300 million capsule units, and 100 million oncology OSD units annually. The company offers a comprehensive portfolio of over 80 finished products spanning multiple therapeutic areas including oncology (with OEB Level-5 containment capability), cardiovascular, anti-infectives, diabetes, CNS, respiratory, dermatology, gastrointestinal, pain management, and gynecology. Pinnacle serves regulated markets (USFDA, MHRA, EU-GMP, ANVISA approved) and emerging markets, supplying medicines to over 90 countries worldwide. The company provides both regulated market products (Apixaban, Sitagliptin, Dapagliflozin, Rivaroxaban) and emerging market generics, with vertical integration through its parent company Aarti Drugs Ltd. for API supply chain resilience.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical CDMO Services End-to-end contract development and manufacturing services for pharmaceutical and biotech clients, including formulation development, clinical trial material manufacturing, commercial-scale production, analytical method development, regulatory dossier preparation, and technology transfer.
• Oncology Medicines Cancer treatment pharmaceuticals including chemotherapy agents, targeted therapies, and supportive oncology medications manufactured under OEB Level-5 containment standards.
• High-Potency HPAPI Manufacturing Specialized contract manufacturing for high-potency active pharmaceutical ingredients (HPAPIs) and cytotoxic compounds requiring OEB Level-5 containment infrastructure.
• ADC Development Services Antibody-drug conjugate (ADC) development and manufacturing services for targeted cancer therapies, including bioconjugation and fill-finish capabilities.
• Cardiovascular Medicines Heart health medications including anticoagulants, anti-hypertensives, anti-platelets, and cholesterol-lowering drugs.
• Anti-infectives Anti-infective medications for treating bacterial, viral, and fungal infections.
• Diabetes Medicines Advanced treatments for diabetes management including Sitagliptin, Dapagliflozin, Linagliptin, and Metformin formulations.
• CNS Medicines Central nervous system medications including anti-depressants, anti-epilepsy, anti-Parkinson, anti-psychotics, and sedatives.
• Respiratory Medicines Respiratory treatments including inhalers (MDI), respules, and related formulations for asthma and COPD management.
• Dermatology Products Topical dermatological products including antifungal creams, anti-psoriasis treatments, and antiseptic ointments.
• Gastrointestinal Medicines GI medications including proton pump inhibitors (PPI), anti-emetics, and treatments for digestive disorders.
• Pain Management Products Analgesics, NSAIDs, and pain management medications including Paracetamol, Ibuprofen, Tramadol, and anti-inflammatory agents.
• Gynecology Products Women's health medications including hormonal treatments, contraceptives, and pregnancy-related therapeutics.
• Vitamins and Supplements Vitamin supplements, calcium formulations, omega fatty acid products, and nutritional supplements.
• Antibiotics Antibiotic medications including Amikacin, Aztreonam, Vancomycin, Meropenem, and other injectable antibiotics.
• Regulated Markets Products Pharmaceutical products for regulated markets including USFDA-approved medications such as Apixaban, Rivaroxaban, Dabigatran, Sitagliptin, and Dapagliflozin in various strengths.
• Emerging Markets Products Generic pharmaceutical products designed for emerging markets including Amoxicillin, Bisoprolol, Fluoxetine, Gliclazide, and other affordable medications.

Quantifiable outcome

• 3 billion tablet units, 300 million capsule units, 100 million oncology OSD units produced annually at Baddi manufacturing facility
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Syngene International: India-based contract development and manufacturing organization serving global pharma with formulation development, clinical and commercial manufacturing, and biologics capabilities. Comparable as a large Indian CDMO serving multinational pharma clients.
• Divi's Laboratories: Indian API and CDMO major with strong HPAPI and large-scale manufacturing capabilities serving regulated markets. Comparable vertically integrated pharma manufacturer with multi-regulatory approvals and oncology exposure.
• Laurus Labs: Indian API, formulation, and CDMO player with USFDA-approved facilities producing generics and ARV APIs for global pharma. Comparable as India-based, USFDA-approved CDMO with regulated-market focus.
• Jubilant Pharmova: Indian pharma and CDMO business with USFDA/EU-GMP-approved facilities providing contract manufacturing, radiopharma, and allergy therapy services. Comparable India-based CDMO with regulated-market approvals.
• Piramal Pharma Solutions: Indian-headquartered CDMO offering end-to-end development and manufacturing across small molecules, HPAPIs, and oncology with multi-regulatory approvals. Most directly comparable on HPAPI oncology CDMO positioning and global regulatory footprint.

Broad incumbents

• Dr. Reddy's Laboratories: Major Indian pharma company with global manufacturing and CDMO services across multiple dosage forms and therapeutic areas. Comparable as a large Indian pharma/CDMO with multi-regulatory approvals and oncology portfolio.
• Aurobindo Pharma: Large Indian generic pharmaceutical manufacturer with substantial USFDA-approved manufacturing and global export footprint. Comparable as a broader Indian pharma incumbent offering generic formulations and contract manufacturing.
• Catalent: Global CDMO with broad oral solid dose, sterile, and biologics manufacturing including HPAPI capabilities. Comparable as a global incumbent CDMO that competes for oncology and complex generics outsourcing work.

Emerging players

• PCI Pharma Services: Global CDMO providing integrated contract development, packaging, and commercial manufacturing services including HPAPI. Comparable as a CDMO peer competing for outsourced pharmaceutical manufacturing and oncology programmes.
• Carbogen Amcis: Swiss-based HPAPI and ADC-focused CDMO with specialized high-containment manufacturing for oncology APIs. Comparable as a specialized HPAPI/ADC CDMO competing for oncology outsourcing programmes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/PinnacleLifeScience
• LinkedInlinkedin.com/company/pinnacle-lifescience-private-limited

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pinnacle Life Science